Search results
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 7 days agoGenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024
Lung Cancer Drug’s 'Off-the-Charts’ Results Give Patients Hope
WebMD· 2 days agoAdam DeMara brushed off new symptoms last fall – feeling of pain in his lower right side, becoming breathless walking up a hill at his golf course – as nothing to worry about, maybe a hernia ...
What Happens to Your Body When You Take Elderberry Regularly
Eating Well via Yahoo News· 4 days agoAngiogenesis is the process by which new blood vessels grow to deliver nutrients to tumors,” says...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoData show favorable safety and feasibility in 68 heavily pre-treated patients with R/M-HNSCC (Intention-to-Treat population; “ITT”) who received RT-activated NBTXR3 followed by anti-PD-1 as a second-or-later line treatment48% ORR in evaluable
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoMEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer PR Newswire CHICAGO, June 2, ...
Sarcoma immunotherapy clinical trial reduces risk of relapse by 43%
Medical Xpress· 4 days agoFor the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare...
'Outstanding' Results for Osimertinib: Stage III EGFR+ NSCLC
Medscape· 5 days agoResults from the LAURA trial will change practice once its label gets expanded, experts said at the...
Study shows ivonescimab improves progression-free survival in EGFR+ lung cancer
Medical Xpress· 2 days agoFor patients with non-small cell lung cancer with the epidermal growth factor receptor (EGFR)...
Philogen and Sun Pharma seek EMA approval for melanoma therapy
Pharmaceutical Technology via Yahoo Finance· 5 days agoIt enrolled 256 subjects across 22 European clinical sites. Nidlegy significantly reduced the...
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC
MedPage Today· 7 days agoEGFR testing now needed for all patients with stage III disease, experts say
